Chemical Computing Group

Stories

Altaris takes drug-simulation software maker Simulations Plus private

As of June 2026: Altaris portfolio company set to absorb Simulations Plus

Simulations Plus agreed on June 16, 2026 to be taken private by Altaris for $18.50 a share, or about $375 million total. Shareholders get a 26% premium over the prior 60-day average. Altaris plans to fold the company into Chemical Computing Group, a molecular-design firm it already owns.

Updated Jun 17